Tag: Blood Glucose Monitors
First OTC Continuous Blood Glucose Monitor Cleared for Marketing by FDA
Dexcom Stelo Glucose Biosensor System is intended for people aged 18 years and older who have T2D but do not take insulin
FDA Warns of Smartwatches That Claim to Measure Glucose Levels
Many companies are illegally marketing smartwatch or smart ring devices that claim to measure blood glucose without piercing the skin
Not Even Private Health Insurance Overcomes Racial Disparities in Glycemic Control
Worse glycemic control seen for Hispanic and Black adults
Decision Support Tool Cuts Hypoglycemia Risk in Older Adults
Decreased use of insulin and sulfonylureas seen postintervention
mHealth-Delivered Coaching Cuts Blood Glucose Levels in Patients With Diabetes
Authors say such interventions may reduce racial, ethnic disparities in diabetes outcomes
Higher Poststroke Glucose Levels Tied to Faster Cognitive Decline
However, no associations seen for blood pressure or cholesterol levels
FDA Clears New Insulin Pump and Algorithm-Based Software
Enhanced automatic insulin delivery system cleared for people with type 1 diabetes ≥6 years
Guidelines Updated for Reducing Hypoglycemia Risk in Diabetes
Strong recommendations include use of glucagon preparations that do not need reconstitution, real-time CGM for those receiving multiple daily injections
Impaired Glucose Homeostasis Seen With Exposure to Artificial Light at Night
Prevalence ratio of 1.28 found for diabetes with highest versus the lowest quintile of exposure to light at night
Glycated Hemoglobin Lower With Continuous Glucose Monitoring in T1DM
Glycated hemoglobin levels lower and time spent in glucose target range greater with use of intermittently scanned CGM versus fingerstick testing
